Medicalgorithmics (WAR:MDG) Cyclically Adjusted Revenue per Share: zł39.29 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

WAR:MDG Medicalgorithmics SA WAR:MDG
72 GF Score
Price zł26.60
GF Value zł27.45
Valuation Fairly Valued
! 4 Warning Signs
View Full Analysis

What is Medicalgorithmics Cyclically Adjusted Revenue per Share?

Medicalgorithmics WAR:MDG -0.93% 72 Cyclically Adjusted Revenue per Share is zł39.29 as of Mar. 2026. GuruFocus rates WAR:MDG with a GF Score™ of 72/100 and a GF Value™ of zł27.45 (Fairly Valued). The stock has 4 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Medicalgorithmics's adjusted revenue per share for the three months ended in Mar. 2026 was zł1.028. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is zł39.29 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Medicalgorithmics's average Cyclically Adjusted Revenue Growth Rate was -1.60% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 1.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Medicalgorithmics was 8.60% per year. The lowest was 1.60% per year. And the median was 5.10% per year.

As of today (2026-07-26), Medicalgorithmics's current stock price is zł26.60. Medicalgorithmics's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2026 was zł39.29. Medicalgorithmics's Cyclically Adjusted PS Ratio of today is 0.68.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Medicalgorithmics was 1.15. The lowest was 0.17. And the median was 0.66.


Medicalgorithmics  (WAR:MDG) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Medicalgorithmics's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=26.60/39.29
=0.68

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Medicalgorithmics was 1.15. The lowest was 0.17. And the median was 0.66.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Medicalgorithmics Cyclically Adjusted Revenue per Share Related Terms


Medicalgorithmics Cyclically Adjusted Revenue per Share Historical Data

* Premium members only.

The historical data trend for Medicalgorithmics's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Medicalgorithmics Cyclically Adjusted Revenue per Share Chart

Medicalgorithmics Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 31.06 36.93 38.99 39.74 38.73

Medicalgorithmics Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 39.92 39.55 39.18 38.73 39.29

WAR:MDG vs ABT, SYK, MDT: Cyclically Adjusted Revenue per Share Comparison

For the Medical Devices subindustry, Medicalgorithmics's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Medicalgorithmics Cyclically Adjusted PS Ratio vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Medicalgorithmics's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Medicalgorithmics's Cyclically Adjusted PS Ratio falls into.


WAR:MDG
72GF Score
Medicalgorithmics SA WAR:MDG
Cyclically Adjusted Revenue per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Medicalgorithmics Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Medicalgorithmics's adjusted Revenue per Share data for the three months ended in Mar. 2026 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=1.028/163.0700*163.0700
=1.028

Current CPI (Mar. 2026) = 163.0700.

Medicalgorithmics Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201606 9.610 99.552 15.742
201609 9.951 99.064 16.380
201612 9.622 100.366 15.633
201703 11.490 101.018 18.548
201706 16.812 101.180 27.096
201709 13.923 101.343 22.403
201712 14.003 102.564 22.264
201803 12.335 102.564 19.612
201806 13.744 103.378 21.680
201809 13.465 103.378 21.240
201812 15.782 103.785 24.797
201903 13.500 104.274 21.112
201906 12.629 105.983 19.432
201909 11.687 105.983 17.982
201912 10.429 107.123 15.876
202003 10.001 109.076 14.952
202006 6.389 109.402 9.523
202009 5.828 109.320 8.693
202012 6.346 109.565 9.445
202103 7.247 112.658 10.490
202106 5.094 113.960 7.289
202109 2.656 115.588 3.747
202112 2.532 119.088 3.467
202203 2.596 125.031 3.386
202206 2.769 131.705 3.428
202209 3.503 135.531 4.215
202212 2.357 139.113 2.763
202303 1.134 145.950 1.267
202306 0.938 147.009 1.040
202309 1.075 146.113 1.200
202312 1.260 147.741 1.391
202403 0.705 149.044 0.771
202406 0.594 150.997 0.641
202409 0.515 153.439 0.547
202412 0.589 154.660 0.621
202503 0.680 157.021 0.706
202506 0.699 157.509 0.724
202509 0.727 158.000 0.750
202512 1.010 158.320 1.040
202603 1.028 163.070 1.028

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

What does a Cyclically Adjusted Revenue per Share of zł39.29 mean?
Medicalgorithmics (WAR:MDG) has a Cyclically Adjusted Revenue per Share of zł39.29 as of Mar. 2026. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Medicalgorithmics and its competitors.
Is Medicalgorithmics' Cyclically Adjusted Revenue per Share too high?
Medicalgorithmics' current Cyclically Adjusted Revenue per Share is zł39.29. Overall, Medicalgorithmics has a GF Score™ of 72/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Medicalgorithmics' Cyclically Adjusted Revenue per Share compare to ABT and SYK?
Medicalgorithmics' Cyclically Adjusted Revenue per Share of zł39.29 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Revenue per Share for a Medical Devices & Instruments company?
A good Cyclically Adjusted Revenue per Share depends on the Medical Devices & Instruments industry context. However, Cyclically Adjusted Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Revenue per Share mean?
A high Cyclically Adjusted Revenue per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Medicalgorithmics and its competitors. Medicalgorithmics's current Cyclically Adjusted Revenue per Share is zł39.29. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medicalgorithmics stock overvalued right now?
Based on GuruFocus' analysis, Medicalgorithmics (WAR:MDG) is currently considered Fairly Valued. The stock's GF Value™ is zł27.45, compared to a current price of zł26.60 — trading 3.1% below its estimated fair value. The current Cyclically Adjusted Revenue per Share is zł39.29. Medicalgorithmics' overall GF Score™ is 72/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Revenue per Share calculated?
Cyclically Adjusted Revenue per Share is calculated from a company's financial statements. For Medicalgorithmics (WAR:MDG), the current Cyclically Adjusted Revenue per Share is zł39.29 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Medicalgorithmics (WAR:MDG) Overvalued in 2026?

Based on GuruFocus' analysis, Medicalgorithmics stock appears to be undervalued. The current stock price of zł26.60 is trading 3.1% below its estimated GF Value™ of zł27.45. GuruFocus considers Medicalgorithmics to be Fairly Valued.

Key valuation signals for WAR:MDG:

  • Cyclically Adjusted Revenue per Share: zł39.29
  • GF Value™: zł27.45 vs. price of zł26.60 (3.1% below fair value)
  • GF Score™: 72/100 with 4 warning signs

No single metric tells the full story. See the WAR:MDG stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Medicalgorithmics Business Description

Address Al Jerozolimskie 81, 19 Floor, Central Tower Building, Warsaw, POL, 02-001
Medicalgorithmics SA is a medical technology company. It is engaged in the development of Digital Signal Processing (DSP) algorithms development and software and hardware electronics design for medical applications. The company specializes in providing advance technological solutions in the field of cardiac diagnostics, with a particular focus on ECG signal analysis. The group concentrates on the production and development of its flagship product Pocket ECG - a system for remote monitoring of cardiac arrhythmias. The offered solutions include algorithms and diagnostic systems used in remote heart monitoring. The company operates in Poland, the USA, and other, with majority of revenue from the USA.
72GF Score

Get the complete analysis for WAR:MDG

Cyclically Adjusted Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

zł26.60
Price
zł27.45
GF Value